Translate
Janux Therapeutics Inc
About
Janux Therapeutics Inc (NASDAQ:JANX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Janux Therapeutics Announces First Participant Dosed in Phase 1 Study of JANX014
Apr 1 2026
Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment
Feb 26 2026
Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Feb 17 2026
Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX011
Jan 26 2026
Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer
Recent Videos
How to Buy Janux Therapeutics Inc Stock (JANX)
Mar 25, 2026
The Founder and CEO of Janux describes the idea behind the company’s masked T-Cell engagers.
Mar 13, 2026
Janux Therapeutics & BMS Deal: My Biggest Insight
Jan 25, 2026
Janux Therapeutics, janx stock analysis buy or sell
Dec 03, 2025
Financials
Revenue
$10 M
Market Cap
$902.74 M
EPS
-1.83
